Baxter Healthcare Corporation recalls Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules, Rx
Baxter Healthcare recalls spinal anesthetic ampules with black and transparent particles. Stop using if you have these specific lots. No remedy provided in official notice.
Stop using this now
Presence of particulate matter in solution - black and transparent particles
Contact the company & request your remedy
What happened, in plain English
Baxter Healthcare is recalling spinal anesthetic injections that may contain black and transparent particles. This could cause serious injury if injected into the spinal area. The recall affects specific lots manufactured in India and the US. Read more at govinfonow.com/recall/36733-baxter-spinal-bupivacaine-recall-particulate-matter-in-injection.
Source Summary by GovInfoNow · govinfonow.com/recall/36733-baxter-spinal-bupivacaine-recall-particulate-matter-in-injection · Updated October 4, 2026 · FDA enforcement record: FDA #D-0076-2021
Cite this page
“Baxter Spinal Bupivacaine Recall: Particulate Matter in Injection.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36733-baxter-spinal-bupivacaine-recall-particulate-matter-in-injection. Based on FDA recall #D-0076-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0076-2021%22&limit=1).
Why it’s dangerous
Particulate matter in the solution can cause blockages or irritation when injected into the spinal area. This may lead to serious complications such as infection, nerve damage, or other injuries.
Who’s affected
Healthcare professionals who use these spinal anesthetic injections for medical procedures. Patients receiving spinal anesthesia from providers using recalled lots are at risk.
How to tell if you have this one
Check for the product name: Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules. Look for lot numbers A0B1241 (exp 10/2020), A0C0091 (exp 12/2020), or A0D0268 (exp 02/2022).
- Brand
Baxter- Category
Drug
What to do — step by step
Stop Using Now
Immediately stop using the recalled spinal anesthetic injections if you have them.
Questions people ask
Why is this product being recalled?
The product contains black and transparent particles that could cause serious injury if injected into the spinal area.
What should I do if I have this product?
Stop using it immediately. The official recall notice does not provide a remedy for returning or discarding the product.
Which lots are affected?
Lots A0B1241 (exp 10/2020), A0C0091 (exp 12/2020), and A0D0268 (exp 02/2022).
Contact Baxter
We’ve drafted a message you can send Baxter to request your refund or repair — edit it as you like.
Subject: Recall D-0076-2021 — Baxter Baxter Hello, I own a Baxter that is covered by recall D-0076-2021 from Baxter. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0076-2021 (October 7, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0076-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.